RecruitingNCT07358910
Rare condition
Japanese encephalitis
2
studies recruiting now
as of 7 Sept 2026
85
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
22 Jan 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1 / Phase 2NCT06680128
A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults
Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Japanese encephalitis studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Japanese encephalitis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Japanese encephalitis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
5 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Satralizumab (Enspryng)
Phase 3Sodium Chloride (Aqsia (balanced salt soln))
Phase 3Japanese Encephalitis Virus, Inactivated (Ixiaro)
Phase 2Rituximab (Blitzima)
Phase 2Ribavirin (Copegus)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).